The phenotype of Lrig2E12-/- mice was distinct from that of the previously described Lrig1- and Lrig3-mutant mice, and included increased spontaneous mortality, transiently reduced growth rate, and protection against PDGFB-induced glioma. The gene discussed is LRIG3; the disease is central nervous system cancer.